| Patient | Jane Austen |
|---|---|
| Date of birth | 1985-12-16 |
| Identifiers | MRN HR-EN014-SYN; SSN (made up) 000-14-6317 |
| Document date | 2026-07-27 |
| Author | Harriet Pemberton-Okafor, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Periodic adult preventive visit. [S]
Ms. Austen is a 40-year-old novelist with primary adrenal insufficiency diagnosed four months ago, on hydrocortisone and fludrocortisone, who comes for her yearly preventive visit. She finished the draft of the novel she was writing earlier this month and says she has not had such a run of good mornings for a year. She walks to the market town and back most days. She has had no illness needing stress doses since the sore throat in the spring, and she carries her injection kit and wears her medical ID. Her periods are regular. She has no new concerns. [S]
| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 40 |
| Adrenal insufficiency | Well on hydrocortisone 10 mg and 5 mg and fludrocortisone 0.1 mg; no crisis |
| Weight | 56.6 kg, from 52.0 kg at diagnosis |
| Mood | PHQ-2 0; GAD-7 2 |
Health risk assessment. Completed by the patient on paper in the waiting room and reviewed with her by Dr. Pemberton-Okafor. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Good, and much better than in the spring |
| Psychosocial | Absorbing work; close family and friends; no financial strain she wishes to discuss |
| Substance use | AUDIT-C 1; no drug use |
| Tobacco | Never uses tobacco |
| Physical activity | Walks several miles most days |
| Nutrition | Regular meals with salt to taste; dairy daily |
| Sleep | Seven to eight hours on most nights |
| Safety | Wears a seat belt; no firearm at home; feels safe at home (intimate partner violence screen negative) |
| Sexual and reproductive health | Not sexually active; not planning pregnancy; periods regular |
| Activities of daily living | Independent |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever, weight loss, night sweats, or unusual tiredness |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | No sore throat or mouth ulcers |
| Cardiovascular | Negative | No lightheadedness on standing, palpitations, or ankle swelling |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | No nausea, abdominal pain, or salt craving |
| Genitourinary | Negative | Regular periods; no urinary symptoms |
| Musculoskeletal | Negative | No back ache since the spring |
| Integumentary | Negative | Darkening of the skin fading; no changing moles |
| Breast | Negative | No lump, pain, or nipple discharge |
| Endocrine | Negative | No cold or heat intolerance or thirst |
| Hematologic and lymphatic | Negative | No lumps in the neck, armpits, or groin; no easy bruising |
| Psychiatric | Negative | Mood good; PHQ-2 0, GAD-7 2 |
13 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Hydrocortisone 10 mg oral tablet, one tablet by mouth on waking | One tablet by mouth on waking | Oral route | 2026-03-19 | active | S |
| Hydrocortisone 5 mg oral tablet, one tablet by mouth at 2 pm | One tablet by mouth at 2 pm | Oral route | 2026-03-19 | active | S |
| Fludrocortisone 0.1 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning | Oral route | 2026-03-19 | active | S |
| Hydrocortisone 100 mg injection kit (with diluent), 100 mg into the thigh muscle once for vomiting, collapse or signs of adrenal crisis, then call 911 | Once, as needed for adrenal crisis; carry at all times | Intramuscular route | 2026-03-19 | active | S |
| Amoxicillin 500 mg oral capsule, one capsule by mouth twice daily for ten days | One capsule twice daily for ten days | Oral route | 2026-04-20 to 2026-04-29 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-07-27 | Body height | 170 | cm | S |
| 2026-07-27 | Body weight | 56.6 | kg | S |
| 2026-07-27 | Body mass index (BMI) [Ratio] | 19.6 | kg/m2 | S |
| 2026-07-27 | Systolic blood pressure | 114 | mm[Hg] | S |
| 2026-07-27 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-07-27 | Heart rate | 70 | /min | S |
| 2026-07-27 | Respiratory rate | 14 | /min | S |
| 2026-07-27 | Body temperature | 36.6 | Cel | S |
| 2026-07-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-07-27 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 2026-07-27 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 2 | {score} | S | ||
| 2026-07-27 | Total score [AUDIT-C] | 1 | {score} | S | ||
| 2026-07-27 | Cholesterol [Mass/volume] in Serum or Plasma | 182 | mg/dL | <=199 mg/dL | Normal | S |
| 2026-07-27 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 68 | mg/dL | >=50 mg/dL | Normal | S |
| 2026-07-27 | Triglyceride [Mass/volume] in Serum or Plasma | 74 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-07-27 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 99 | mg/dL | <=99 mg/dL | Normal | S |
Vital signs recorded on 2026-07-27; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Well; weight 56.6 kg, BMI 19.6; blood pressure 114/72 seated, 112/72 standing |
| Skin | Faint residual brown pigmentation of the palmar creases and gums; no suspicious moles; no thin skin, striae, or bruising |
| Mouth | Teeth in good repair |
| Neck | Thyroid normal; no cervical or supraclavicular nodes |
| Lymph nodes | No axillary or inguinal nodes |
| Breasts | Clinical breast examination declined; no concerns raised |
| Cardiovascular | Regular rhythm; no murmur; no ankle edema |
| Respiratory | Clear to auscultation bilaterally |
| Abdomen | Soft and non-tender; no enlarged liver or spleen |
| Pelvic | Speculum examination with a chaperone present; cervix normal; sample taken for HPV testing |
| Psychiatric | Bright and engaged |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| About three months of increasing tiredness, loss of 5 kg, darkening of the skin, nausea with bouts of vomiting, low back ache, salt craving and lightheadedness on standing, with low sodium, high potassium and raised eosinophils; adrenal insufficiency suspected and urgent endocrinology testing booked | resolved | confirmed | R53.83 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis at the consultation; its timing echoes the documented break in her health (D). |
| Primary adrenal insufficiency (Addison's disease): no cortisol response to cosyntropin with a markedly raised ACTH, and mineralocorticoid deficiency with raised renin and low aldosterone; on hydrocortisone and fludrocortisone; synthetic modern diagnosis chosen for a historical illness whose cause is disputed | active | confirmed | E27.1 | S — Synthetic modern diagnosis; the historical cause of her illness remains undetermined (R, disputed). |
| Mild normocytic anemia (hemoglobin 11.4 g/dL) with normal ferritin, vitamin B12 and folate | resolved | confirmed | D64.9 | S — Synthetic finding at intake; it recovers on replacement. |
| Group A streptococcal pharyngitis with fever, treated with amoxicillin and doubled hydrocortisone under the sick-day rules; resolved | resolved | confirmed | J02.0 | S — Synthetic intercurrent illness; not a historical claim. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 114/72 mmHg seated; no postural drop |
| Depression screening | Completed today | PHQ-2 score 0 |
| Anxiety screening | Completed today | GAD-7 score 2 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C score 1 |
| Tobacco use | Completed today | Never uses tobacco |
| Intimate partner violence screening | Completed today | Negative; feels safe at home |
| Lipid screening and statin assessment | Completed today | Total cholesterol 182, HDL 68, LDL 99 mg/dL; very low ten-year risk; no statin |
| Diabetes screening | Up to date | Not due by weight; A1c checked in the spring as part of autoimmune screening, and repeated yearly for that reason |
| Breast cancer screening | Ordered | Biennial mammography from 40; first screening mammogram booked |
| Cervical cancer screening | Completed today | No record of earlier screening; high-risk HPV test collected today; repeat every five years if negative |
| Colorectal cancer screening | Not indicated | Begins at 45 |
| HIV screening | Completed today | Once for adults 15 to 65; sent today |
| Hepatitis C screening | Completed today | Once for adults 18 to 79; sent today |
| Hepatitis B screening | Completed today | Once for all adults (surface antigen, surface antibody and core antibody); sent today before the first vaccine dose |
| Osteoporosis screening | Not indicated | Under 65 without added risk; hydrocortisone at replacement doses does not raise fracture risk |
| Folic acid | Not indicated | Not sexually active and not planning pregnancy; she will start folic acid if that changes |
| Tetanus, diphtheria, and pertussis | Completed today | Tdap; no record of a booster within ten years |
| Hepatitis B vaccine | Completed today | No record of vaccination; dose 1 of 2 today, dose 2 at the autumn review |
| Influenza vaccine | Due | At the autumn review |
| COVID-19 vaccine | Due | Discuss in the autumn with the influenza vaccine |
| Human papillomavirus vaccine | Not indicated | Routine vaccination ends at 26 and shared decision-making ends at 45; not sexually active, and she chose not to have it |
| Medical ID and emergency kit | Up to date | Wears a medical ID; injection kit in date; steroid emergency card in her purse |
Immunizations given today: Tetanus, diphtheria, and acellular pertussis vaccine (Tdap); Hepatitis B vaccine (HepB-CpG), dose 1 of 2 [S]
Guideline basis: Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)
Follow-up: Six-month review in the autumn with electrolytes, renin, TSH, the PHQ-9, the second hepatitis B dose and the influenza vaccine. HIV, hepatitis B, hepatitis C and HPV results by phone. Mammogram as booked. Next preventive visit in one year. Next scheduled visit 2026-10-12: seven-month review: replacement, renin, thyroid, mood, and the closing of the differential. [S]
Voluntary advance care planning discussion of about 20 minutes, with her consent. She wants full treatment in any emergency, and wants emergency staff to give hydrocortisone at once if she is found unwell; a copy of her emergency letter is in the chart and in her purse. She named a health care agent, recorded in the confidential part of the chart and not named here, and chose not to record other treatment preferences today. To be revisited yearly. [S]